| Well, I'll answer my own question.
I received the annual report. The company produces a variety of medical
test kits. They aren't heavily in debt, but 1992 was their first
profitable year.
The stock trades at roughly 100 times earnings, but several predictions
I've seen lately are looking for a rapid earnings increase over the
next two years.
One big problem (for me, anyway) is that over 50% of their revenue
comes from one customer. They have significantly cut operating
expenses, increased research funding, and increased sales and marketing
expenditures as part of a new (and so far successful) marketing
strategy.
They look ok, but I'm not overwhelmed.
Marie
|